Combo Product Appeals Low In Number, But Lengthy In Decision Time
Executive Summary
US FDA needs to establish timelines for decisions on appeals of requests for designations of combination products, industry expert says; FDA contends that decisions on appeals carry significant implications, and require thorough reviews.